Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP567284.RAvWH5LNRfKmLsmp494CErCgGhOX2UmVmhAnmwAyXJstE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP567284.RAvWH5LNRfKmLsmp494CErCgGhOX2UmVmhAnmwAyXJstE130_assertion type Assertion NP567284.RAvWH5LNRfKmLsmp494CErCgGhOX2UmVmhAnmwAyXJstE130_head.
- NP567284.RAvWH5LNRfKmLsmp494CErCgGhOX2UmVmhAnmwAyXJstE130_assertion description "[Primary screening with HC2 generally detects 23% (95% confidence interval, CI: 13-23%) more CIN-2, CIN-3, or cancer compared to cytology at cut-off atypical squamous cells of undetermined significance (ASCUS) or LSIL, but is 6% (95% CI: 4-8%) less specific.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567284.RAvWH5LNRfKmLsmp494CErCgGhOX2UmVmhAnmwAyXJstE130_provenance.
- NP567284.RAvWH5LNRfKmLsmp494CErCgGhOX2UmVmhAnmwAyXJstE130_assertion evidence source_evidence_literature NP567284.RAvWH5LNRfKmLsmp494CErCgGhOX2UmVmhAnmwAyXJstE130_provenance.
- NP567284.RAvWH5LNRfKmLsmp494CErCgGhOX2UmVmhAnmwAyXJstE130_assertion SIO_000772 16950021 NP567284.RAvWH5LNRfKmLsmp494CErCgGhOX2UmVmhAnmwAyXJstE130_provenance.
- NP567284.RAvWH5LNRfKmLsmp494CErCgGhOX2UmVmhAnmwAyXJstE130_assertion wasDerivedFrom befree-2016 NP567284.RAvWH5LNRfKmLsmp494CErCgGhOX2UmVmhAnmwAyXJstE130_provenance.
- NP567284.RAvWH5LNRfKmLsmp494CErCgGhOX2UmVmhAnmwAyXJstE130_assertion wasGeneratedBy ECO_0000203 NP567284.RAvWH5LNRfKmLsmp494CErCgGhOX2UmVmhAnmwAyXJstE130_provenance.